ConductScience.org, home

Paper20163115

Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.

Ahmed AH and 1 other. J Med Chem, 2010. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. Papers, record 20163115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20163115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
PubMed
Journal
J Med Chem
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
1.6
iCite
Revised in PubMed
2025-05-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahmed AHAhmed H
2Oswald RERobert E

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Nootropic AgentsMajor topic
PiracetamMajor topic
PyrrolidinonesMajor topic
Receptors, AMPAMajor topic
Allosteric Regulation
Binding Sites
Humans
Mutagenesis, Insertional
X-Ray Diffraction

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 NS049223NINDS NIH HHSUnited StatesR01NS049223PubMed and NIHNIH RePORTER
DMR-0225180NIGMS NIH HHSUnited StatesPubMedPubMed
1R21-NS067562NINDS NIH HHSUnited StatesR21NS067562PubMed and NIHNIH RePORTER
R01-NS049223NINDS NIH HHSUnited StatesR01NS049223PubMed and NIHNIH RePORTER
R21 NS067562NINDS NIH HHSUnited StatesR21NS067562PubMed and NIHNIH RePORTER
P41 RR001646NCRR NIH HHSUnited StatesP41RR001646PubMed and NIHNIH RePORTER
RR-01646NCRR NIH HHSUnited StatesP41RR001646PubMed and NIHNIH RePORTER
R01 GM068935NIGMS NIH HHSUnited StatesR01GM068935PubMed and NIHNIH RePORTER

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117275103Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death.Trends Neurosci2007https://conductscience.org/library/papers/17275103PubMed
29804426Structure of a glutamate-receptor ligand-binding core in complex with kainate.Nature1998https://conductscience.org/library/papers/9804426PubMed
316215279AMPA receptor subunit GluR2 gates injurious signals in ischemic stroke.Mol Neurobiol2005https://conductscience.org/library/papers/16215279PubMed
41372342Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures.J Neurochem1992https://conductscience.org/library/papers/1372342PubMed
51681589Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam.Science1991https://conductscience.org/library/papers/1681589PubMed
615677325Structure of the kainate receptor subunit GluR6 agonist-binding domain complexed with domoic acid.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15677325PubMed
716192394Mechanism of positive allosteric modulators acting on AMPA receptors.J Neurosci2005https://conductscience.org/library/papers/16192394PubMed
81975272Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.J Physiol1990https://conductscience.org/library/papers/1975272PubMed
918022568Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites.Chem Biol2007https://conductscience.org/library/papers/18022568PubMed
1019003990Structure of the S1S2 glutamate binding domain of GLuR3.Proteins2009https://conductscience.org/library/papers/19003990PubMed
1119102704Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists.Biochemistry2008https://conductscience.org/library/papers/19102704PubMed
1217237803Regulatory mechanisms of AMPA receptors in synaptic plasticity.Nat Rev Neurosci2007https://conductscience.org/library/papers/17237803PubMed
1317581823
Partial agonism and antagonism of the ionotropic glutamate receptor iGLuR5: structures of the ligand-binding core in complex with domoic acid and 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid.
J Biol Chem2007https://conductscience.org/library/papers/17581823PubMed
1416442080A role for AMPA receptors in mood disorders.Biochem Pharmacol2006https://conductscience.org/library/papers/16442080PubMed
1517256974GluR3 flip and flop: differences in channel opening kinetics.Biochemistry2007https://conductscience.org/library/papers/17256974PubMed
167973663A molecular determinant for submillisecond desensitization in glutamate receptors.Science1994https://conductscience.org/library/papers/7973663PubMed
1711086992Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.Neuron2000https://conductscience.org/library/papers/11086992PubMed
1810049997The glutamate receptor ion channels.Pharmacol Rev1999https://conductscience.org/library/papers/10049997PubMed
1912215417Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.J Mol Biol2002https://conductscience.org/library/papers/12215417PubMed
2011518533Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.J Mol Biol2001https://conductscience.org/library/papers/11518533PubMed

See all 47 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
42438577Differential Improvement in Obsessive Rumination and Fantasy Intrusions Versus Attachment-Related Emotional Dysregulation During Oral Glutamatergic Augmentation in a 16-Year-Old Adolescent.Cureus2026https://conductscience.org/library/papers/42438577PubMed
42368238
Optimized Oral Glutamatergic Augmentation in Refractory Home-Dominant Contamination Obsessive-Compulsive Disorder With Somatic, Affective, and Motivational Features: A Case Report of Incremental Functional Gains.
Cureus2026https://conductscience.org/library/papers/42368238PubMed
42205993Case Report: Oral glutamatergic augmentation for trauma-related disorders with fluoxetine-/bupropion-potentiated dextromethorphan ± piracetam: a four-patient case series.Front Psychiatry2026https://conductscience.org/library/papers/42205993PubMed
42005166Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features.Cureus2026https://conductscience.org/library/papers/42005166PubMed
41739317Oxiracetam Improves Cognitive Disorder in AD by Modulating AMPAR Subunits GluA1/GluA2 Kinetics.Cell Biochem Biophys2026https://conductscience.org/library/papers/41739317PubMed
41732374Glutamatergic Enhancement Using As-Needed Dextromethorphan and Piracetam in a Stimulant-Partially Responsive Adult With ADHD: A Single-Case Report.Cureus2026https://conductscience.org/library/papers/41732374PubMed
38552113Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease.J Alzheimers Dis2024https://conductscience.org/library/papers/38552113PubMed
36857176Positive and negative allosteric modulation of GluK2 kainate receptors by BPAM344 and antiepileptic perampanel.Cell Rep2023https://conductscience.org/library/papers/36857176PubMed
36552791Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain.Cells2022https://conductscience.org/library/papers/36552791PubMed
35743382Effects of Smart Drugs on Cholinergic System and Non-Neuronal Acetylcholine in the Mouse Hippocampus: Histopathological Approach.J Clin Med2022https://conductscience.org/library/papers/35743382PubMed
35366192Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.Drugs2022https://conductscience.org/library/papers/35366192PubMed
35298129How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets?ACS Chem Neurosci2022https://conductscience.org/library/papers/35298129PubMed
34909030Neuroenhancement: State of the Art and Future Perspectives.Clin Neuropsychiatry2021https://conductscience.org/library/papers/34909030PubMed
34753794Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.Pharmacol Rev2021https://conductscience.org/library/papers/34753794PubMed
32894462The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors.Dokl Biochem Biophys2020https://conductscience.org/library/papers/32894462PubMed
32468591Hodgkin-Huxley-Katz Prize Lecture: Genetic and pharmacological control of glutamate receptor channel through a highly conserved gating motif.J Physiol2020https://conductscience.org/library/papers/32468591PubMed
32013012Integrated Computational Approaches and Tools forAllosteric Drug Discovery.Int J Mol Sci2020https://conductscience.org/library/papers/32013012PubMed
30864515Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline.Curr Aging Sci2019https://conductscience.org/library/papers/30864515PubMed
30581496Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel.Behav Neurol2018https://conductscience.org/library/papers/30581496PubMed
28674068Structural and Functional Analysis of the Escherichia coli Acid-Sensing Histidine Kinase EvgS.J Bacteriol2017https://conductscience.org/library/papers/28674068PubMed

See all 32 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CFLAR8837PubTator's text mininghttps://conductscience.org/library/genes/8837NCBI Gene
GRIA22891PubTator's text mininghttps://conductscience.org/library/genes/2891NCBI Gene
GRIA32892PubTator's text mininghttps://conductscience.org/library/genes/2892NCBI Gene
GRIA42893PubTator's text mininghttps://conductscience.org/library/genes/2893NCBI Gene
GRIK12897PubTator's text mininghttps://conductscience.org/library/genes/2897NCBI Gene
GRIK22898PubTator's text mininghttps://conductscience.org/library/genes/2898NCBI Gene
GRIN12902PubTator's text mininghttps://conductscience.org/library/genes/2902NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20163115

GET https://conductscience.org/api/papers/v1/20163115/references?page=2